Status
Conditions
Treatments
About
Strengthening outpatient low respiratory tract infection surveillance to document the burden of Respiratory Syncytial Virus (RSV)
Full description
The study protocol is designed with three key components: 1. Build on existing PARI outpatient syndromic surveillance by adding laboratory multiplex testing of LRTI samples (RSV, Influenza, SARS-COV-2) 2. Follow all bronchiolitis through the PARI RWE database and document "patient journey" for 5 years after first medical visit 3. Review the electronic PARI data of three previous seasons in order to document the impact of LRTI attributable to RSV in children < 2 years in France prior to enhanced surveillance
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
3,500 participants in 3 patient groups
Loading...
Central trial contact
Stéphane Béchet, MsC; Corinne Levy, MD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal